SPY417.26+1.39 0.33%
DIA341.86+1.53 0.45%
IXIC14,052.34+13.58 0.10%

Cue Biopharma Q4 EPS $(0.37) Misses $(0.35) Estimate

Cue Biopharma (NASDAQ:CUE) reported quarterly losses of $(0.37) per share which missed the analyst consensus estimate of $(0.35) by 5.71 percent. This is unchanged from the same period last year. 

· 03/16/2021 16:03

Cue Biopharma (NASDAQ:CUE) reported quarterly losses of $(0.37) per share which missed the analyst consensus estimate of $(0.35) by 5.71 percent. This is unchanged from the same period last year.